Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complete Pathological Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02980731
What this trial is testing

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
AbbVie 210
Not applicableLooking for participantsNCT05350722
What this trial is testing

Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients

Who this might be right for
Breast Cancer
Amsterdam UMC, location VUmc 100
Not applicableActive Not RecruitingNCT03460067
What this trial is testing

Omission of Radiation in Patients With Her-2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
University of Kansas Medical Center 12
Testing effectiveness (Phase 2)Temporarily pausedNCT06694454
What this trial is testing

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Carcinoma, Non-Small Cell LungNon-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 60
Large-scale testing (Phase 3)Study completedNCT02126449
What this trial is testing

DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer

Who this might be right for
Fasting Mimicking DietBreast CancerNeoadjuvant Chemotherapy+1 more
Leiden University Medical Center 131
Testing effectiveness (Phase 2)Looking for participantsNCT07586826
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGynecologic Cancers+7 more
Peking University People's Hospital 220
Not applicableUnknownNCT05441098
What this trial is testing

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 1,821
Testing effectiveness (Phase 2)Study completedNCT00787371
What this trial is testing

Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 69
Large-scale testing (Phase 3)Not Yet RecruitingNCT07269691
What this trial is testing

RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer
Pengfei Qiu 194
Not applicableLooking for participantsNCT05976815
What this trial is testing

Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients

Who this might be right for
Breast Cancer
University Institute of Maia 86
Testing effectiveness (Phase 2)Looking for participantsNCT07593976
What this trial is testing

Evaluation of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT for Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in HER2 Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Centre Henri Becquerel 42
Not applicableStudy completedNCT06595758
What this trial is testing

This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR

Who this might be right for
Breast Cancer
Menoufia University 100
Not applicableStudy completedNCT02800317
What this trial is testing

RISAS Procedure in Node Positive Breast Cancer Following NAC

Who this might be right for
Breast NeoplasmNeoadjuvant TherapyAxillary Lymph Nodes+1 more
Erasmus Medical Center 248
Testing effectiveness (Phase 2)WithdrawnNCT03965624
What this trial is testing

Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Assistance Publique - Hôpitaux de Paris
Large-scale testing (Phase 3)WithdrawnNCT05474690
What this trial is testing

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT06276868
What this trial is testing

Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital 71
Post-approval studies (Phase 4)Active Not RecruitingNCT04928261
What this trial is testing

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 52
Not applicableLooking for participantsNCT04293796
What this trial is testing

Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)

Who this might be right for
Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB
N.N. Petrov National Medical Research Center of Oncology 60
Not applicableStudy completedNCT00969657
What this trial is testing

Validation of a Predictive Model After Complete Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Maastricht Radiation Oncology 80
Testing effectiveness (Phase 2)Looking for participantsNCT07635342
What this trial is testing

Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Hebei Medical University Fourth Hospital 182
Next Page